These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29522778)

  • 1. Amelioration by nitric oxide (NO) mimetics on neurobehavioral and biochemical changes in experimental model of Alzheimer's disease in rats.
    Dubey H; Gulati K; Ray A
    Neurotoxicology; 2018 May; 66():58-65. PubMed ID: 29522778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-nitrosoglutathione modulates HDAC2 and BDNF levels in the brain and improves cognitive deficits in experimental model of Alzheimer's disease in rats.
    Dubey H; Dubey A; Gulati K; Ray A
    Int J Neurosci; 2024 Jul; 134(7):777-785. PubMed ID: 36408590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-Nitrosoglutathione Attenuates Oxidative Stress and Improves Retention Memory Dysfunctions in Intra-Cerebroventricular-Streptozotocin Rat Model of Sporadic Alzheimer's Disease via Activation of BDNF and Nuclear Factor Erythroid 2-Related Factor-2 Antioxidant Signaling Pathway.
    Dubey H; Ray A; Dubey A; Gulati K
    Neuropsychobiology; 2024; 83(2):101-113. PubMed ID: 38744261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
    Afshar S; Shahidi S; Rohani AH; Komaki A; Asl SS
    Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ
    Singh L; Singh S
    Neurosci Lett; 2023 Mar; 799():137090. PubMed ID: 36690059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
    Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
    Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
    Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
    Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phycocyanin alleviates ICV-STZ induced cognitive and molecular deficits via PI3-Kinase dependent pathway.
    Agrawal M; Perumal Y; Bansal S; Arora S; Chopra K
    Food Chem Toxicol; 2020 Nov; 145():111684. PubMed ID: 32805344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
    Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M
    J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
    Liu C; Wu Y; Zha S; Liu M; Wang Y; Yang G; Ma K; Fei Y; Zhang Y; Hu X; Yang W; Qian Y
    Brain Res; 2016 Jan; 1631():137-46. PubMed ID: 26656068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of 5-HT
    Afshar S; Shahidi S; Rohani AH; Soleimani Asl S; Komaki A
    J Chem Neuroanat; 2019 Mar; 96():140-147. PubMed ID: 30684605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl Fumarate Alleviates Adult Neurogenesis Disruption in Hippocampus and Olfactory Bulb and Spatial Cognitive Deficits Induced by Intracerebroventricular Streptozotocin Injection in Young and Aged Rats.
    Kurowska-Rucińska E; Ruciński J; Myślińska D; Grembecka B; Wrona D; Majkutewicz I
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
    Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
    Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
    Salkovic-Petrisic M; Knezovic A; Osmanovic-Barilar J; Smailovic U; Trkulja V; Riederer P; Amit T; Mandel S; Youdim MB
    Life Sci; 2015 Sep; 136():108-19. PubMed ID: 26159898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice.
    Babic Perhoc A; Osmanovic Barilar J; Knezovic A; Farkas V; Bagaric R; Svarc A; Grünblatt E; Riederer P; Salkovic-Petrisic M
    Neuropharmacology; 2019 Apr; 148():50-67. PubMed ID: 30571958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate protective effect of Kyotorphin against the late consequences of intracerebroventricular streptozotocin model of Alzheimer's disease.
    Angelova H; Pechlivanova D; Krumova E; Miteva-Staleva J; Kostadinova N; Dzhambazova E; Landzhov B
    Amino Acids; 2019 Nov; 51(10-12):1501-1513. PubMed ID: 31520285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
    Ejaz Ahmed M; Khan MM; Javed H; Vaibhav K; Khan A; Tabassum R; Ashafaq M; Islam F; Safhi MM; Islam F
    Neurochem Int; 2013 Mar; 62(4):492-501. PubMed ID: 23411413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-(1-7) administration attenuates Alzheimer's disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation.
    Chen JL; Zhang DL; Sun Y; Zhao YX; Zhao KX; Pu D; Xiao Q
    Neuroscience; 2017 Mar; 346():267-277. PubMed ID: 28147245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute lipopolysaccharide-induced inflammation in intracerebroventricular-streptozotocin injected rats.
    Murtishaw AS; Heaney CF; Bolton MM; Sabbagh JJ; Langhardt MA; Kinney JW
    Neuropharmacology; 2016 Feb; 101():110-22. PubMed ID: 26327677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer's disease.
    Zhao HL; Cui SY; Qin Y; Liu YT; Cui XY; Hu X; Kurban N; Li MY; Li ZH; Xu J; Zhang YH
    J Ethnopharmacol; 2021 Apr; 269():113725. PubMed ID: 33352241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.